Defeat MSA joins with other American MSA charities in an effort to proclaim March as MSA Awareness Month in every state in the union as well as in the US Congress and Senate! Defeat MSA succeeded in obtaining MSA awareness March proclamations in 2013, 2017 and 2018! We ask for your help in…
Consider A Car Donation To Defeat MSA! Earmark It: MSA Research, Patient Support, Medical Education, Public Awareness OR All 4 Goals! DONATE HERE!
FOR IMMEDIATE RELEASE Philadelphia Marathon New Tee Drive! LET’S BUILD A HUGE RESEARCH & SUPPORT FUND! Let’s Really Start To Move For MSA -Nov 18, 2017 & Beyond! ** VARIETY in Male & Female & Unisex Styles: Standard Zip-Ups Crew Neck Youth Sizes Pull-Overs Long-Sleeved Tank-Tops Check Out Our Special…
FOR IMMEDIATE RELEASE DATE: September 8, 2017 FROM: Philip Fortier, Director CONTACT: EMAIL: defeatmsa@gmail.com; TEL: 586.246.1475 Defeat MSA’s Board of Directors is pleased to announce the creation of six new Legacy Grants to help fund the charity’s three tiered objectives: medical education, patient support and promising scientific research. Five of the six legacy…
FOR IMMEDIATE RELEASE: Major Art Opening in St Louis “Painting with MSA” – The Art of Rey Umali Please join us at Saint Louis’ MAD ART GALLERY on September 1, 7pm-10pm (CST)! Please help a good cause while enjoying a wonderful evening of art and camaraderie! Exhibit proceeds to benefit Defeat MSA –…
FOR IMMEDIATE RELEASE: Thursday, August 4, 2016 Contact: Philip Fortier, Director – Defeat MSA Phone: (586) 246-1475 Email: DefeatMSA@gmail.com Defeat MSA Leads Kickstarter for New Documentary About MSA! Defeat MSA is pleased to announce the beginning of the Kickstarter campaign to support “1,000 Dias” (1,000 Days), the first full length feature film about…
Several neurodegenerative disorders are caused by aggregates of a single protein known as alpha-synuclein. In collaboration with CNRS and the University of Antwerp, KU Leuven neurobiologists have discovered that the shape of these aggregates – ‘cylinders’ or ‘ribbons’ – determines whether a patient develops Parkinson’s disease or Multiple System Atrophy, respectively. Typical of…
